Literature DB >> 26660147

5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids!

Tobias Else1, Carlos Rodriguez-Galindo2,3.   

Abstract

Adrenocortical carcinoma (ACC) affects children and adults. Roughly 50% of very early onset ACCs occur in children with germline TP53 mutations. Several recent studies have extended our understanding in basic, clinical, and translational genetics with regard to TP53 germline predisposition in ACC patients. The recent description of the molecular landscape of pediatric ACCs provided insight into differences of tumors arising in patients with and without TP53 germline mutation. Another recent important finding is that not all TP53 mutations are equal in their tumor suppressing potential. It has now been shown that family histories as well as molecular characteristics of preserved TP53 functions vary greatly between mutations. It also has become clear that adult patients with ACC often harbor germline mutations causing hereditary syndromes, including Li-Fraumeni syndrome (LFS), Lynch syndrome, and multiple endocrine neoplasia type 1 (MEN1).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26660147     DOI: 10.1007/s12672-015-0244-z

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  20 in total

Review 1.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

2.  Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

Authors:  Jonathan D Wasserman; Ana Novokmet; Claudia Eichler-Jonsson; Raul C Ribeiro; Carlos Rodriguez-Galindo; Gerard P Zambetti; David Malkin
Journal:  J Clin Oncol       Date:  2015-01-12       Impact factor: 44.544

3.  Carney complex with adrenal cortical carcinoma.

Authors:  Emilie Morin; Ozgur Mete; Jonathan D Wasserman; Anthony Michael Joshua; Sylvia L Asa; Shereen Ezzat
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

4.  A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.

Authors:  João Anselmo; Sandra Medeiros; Victor Carneiro; Elizabeth Greene; Isaac Levy; Maria Nesterova; Charalampos Lyssikatos; Anelia Horvath; J Aidan Carney; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

5.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.

Authors:  Heather Hampel; Wendy Frankel; Jenny Panescu; Janet Lockman; Kaisa Sotamaa; Daniel Fix; Ilene Comeras; Jennifer La Jeunesse; Hidewaki Nakagawa; Judith A Westman; Thomas W Prior; Mark Clendenning; Pamela Penzone; Janet Lombardi; Patti Dunn; David E Cohn; Larry Copeland; Lynne Eaton; Jeffrey Fowler; George Lewandowski; Luis Vaccarello; Jeffrey Bell; Gary Reid; Albert de la Chapelle
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

6.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

7.  Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database.

Authors:  B Gatta-Cherifi; O Chabre; A Murat; P Niccoli; C Cardot-Bauters; V Rohmer; J Young; B Delemer; H Du Boullay; M F Verger; J M Kuhn; J L Sadoul; Ph Ruszniewski; A Beckers; M Monsaingeon; E Baudin; P Goudet; A Tabarin
Journal:  Eur J Endocrinol       Date:  2011-11-14       Impact factor: 6.664

8.  Integrated genomic characterization of adrenocortical carcinoma.

Authors:  Guillaume Assié; Eric Letouzé; Martin Fassnacht; Anne Jouinot; Windy Luscap; Olivia Barreau; Hanin Omeiri; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Nabila Elarouci; Silviu Sbiera; Matthias Kroiss; Bruno Allolio; Jens Waldmann; Marcus Quinkler; Massimo Mannelli; Franco Mantero; Thomas Papathomas; Ronald De Krijger; Antoine Tabarin; Véronique Kerlan; Eric Baudin; Frédérique Tissier; Bertrand Dousset; Lionel Groussin; Laurence Amar; Eric Clauser; Xavier Bertagna; Bruno Ragazzon; Felix Beuschlein; Rossella Libé; Aurélien de Reyniès; Jérôme Bertherat
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

9.  Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.

Authors:  Victoria M Raymond; Tobias Else; Jessica N Everett; Jessica M Long; Stephen B Gruber; Gary D Hammer
Journal:  J Clin Endocrinol Metab       Date:  2012-11-21       Impact factor: 5.958

10.  Genomic landscape of paediatric adrenocortical tumours.

Authors:  Emilia M Pinto; Xiang Chen; John Easton; David Finkelstein; Zhifa Liu; Stanley Pounds; Carlos Rodriguez-Galindo; Troy C Lund; Elaine R Mardis; Richard K Wilson; Kristy Boggs; Donald Yergeau; Jinjun Cheng; Heather L Mulder; Jayanthi Manne; Jesse Jenkins; Maria J Mastellaro; Bonald C Figueiredo; Michael A Dyer; Alberto Pappo; Jinghui Zhang; James R Downing; Raul C Ribeiro; Gerard P Zambetti
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

View more
  4 in total

Review 1.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

Review 2.  Adrenocortical carcinoma: Pediatric aspects (Review).

Authors:  Florica Sandru; Răzvan-Cosmin Petca; Mara Carsote; Aida Petca; Mihai Cristian Dumitrascu; Adina Ghemigian
Journal:  Exp Ther Med       Date:  2022-02-16       Impact factor: 2.447

Review 3.  Adrenocortical carcinoma - towards genomics guided clinical care.

Authors:  Joakim Crona; Felix Beuschlein
Journal:  Nat Rev Endocrinol       Date:  2019-09       Impact factor: 43.330

Review 4.  Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.

Authors:  Ozgur Mete; Lori A Erickson; C Christofer Juhlin; Ronald R de Krijger; Hironobu Sasano; Marco Volante; Mauro G Papotti
Journal:  Endocr Pathol       Date:  2022-03-14       Impact factor: 4.056

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.